Flucloxacillin Kabi

Šalis: Naujoji Zelandija

kalba: anglų

Šaltinis: Medsafe (Medicines Safety Authority)

Veiklioji medžiaga:

Flucloxacillin sodium monohydrate 1088.1mg equivalent to 1000 mg flucloxacillin

Prieinama:

Fresenius Kabi New Zealand Limited

Dozė:

1000 mg

Vaisto forma:

Powder for injection

Sudėtis:

Active: Flucloxacillin sodium monohydrate 1088.1mg equivalent to 1000 mg flucloxacillin

Recepto tipas:

Prescription

Terapinės indikacijos:

Flucloxacillin Kabi is indicated in adults and children for the following: - The treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. For example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. - Prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery. Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Produkto santrauka:

Package - Contents - Shelf Life: Vial, glass, Type II with Type 1 halobutyl rubber stopper - 5 vials - 24 months from date of manufacture stored at or below 25°C - Vial, glass, Type II with Type 1 halobutyl rubber stopper - 10 vials - 24 months from date of manufacture stored at or below 25°C

Leidimo data:

2023-01-09